These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2365615)

  • 21. [From veterinarian to quality control manager. What is going to change in the Netherlands for the practicing large animal veterinarian under influence of the White Paper about food safety?].
    Lipman LJ; Bijker PG; Snijders JM; Sterneberg-van der Maaten T; van Knapen F
    Tijdschr Diergeneeskd; 2002 Mar; 127(6):184-7. PubMed ID: 11930544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scientific basis for nonapproved use of drugs in veterinary practice.
    Brumbaugh GW
    J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
    [No Abstract]   [Full Text] [Related]  

  • 23. Veterinary biologic issues addressed by USDA.
    Gloyd JS
    J Am Vet Med Assoc; 1990 Oct; 197(8):967-9. PubMed ID: 2243049
    [No Abstract]   [Full Text] [Related]  

  • 24. Extra-label drug use--veterinary practitioner views: companion animals.
    Cleland JL
    J Am Vet Med Assoc; 1993 May; 202(10):1642-4;discussion 1654-58. PubMed ID: 8514572
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulations and standards for licensing veterinary biologics.
    Peacock GV
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):66-71. PubMed ID: 298939
    [No Abstract]   [Full Text] [Related]  

  • 26. The AVMA legislative initiative: practitioners' view.
    Macomber LE
    J Am Vet Med Assoc; 1993 May; 202(10):1677-8;discussion 1684-92. PubMed ID: 8514582
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of manufacture--the EC point of view.
    Meyer P
    Dev Biol Stand; 1992; 79():159-62. PubMed ID: 1286750
    [No Abstract]   [Full Text] [Related]  

  • 28. Animal drugs: future stepchild or pioneer?
    Lambert EI
    Food Drug Law J; 2000; 55(1):33-4. PubMed ID: 12269360
    [No Abstract]   [Full Text] [Related]  

  • 29. Carrying out the responsibility to industry relative to animal biologics.
    Hejl JM
    Proc Annu Meet U S Anim Health Assoc; 1967; 71():50-60. PubMed ID: 5257329
    [No Abstract]   [Full Text] [Related]  

  • 30. Problems associated with veterinary compounding in swine practice.
    McKean JD
    J Am Vet Med Assoc; 1994 Jul; 205(2):279-83. PubMed ID: 7928598
    [No Abstract]   [Full Text] [Related]  

  • 31. Biosimilars legislation awakens data exclusivity debate.
    Hutson S
    Nat Med; 2009 Nov; 15(11):1242. PubMed ID: 19893548
    [No Abstract]   [Full Text] [Related]  

  • 32. Application of good manufacturing practice regulations to investigational biologic products.
    Goebel PW
    J Parenter Drug Assoc; 1980; 34(5):348-51. PubMed ID: 6905865
    [No Abstract]   [Full Text] [Related]  

  • 33. Summary of Veterinary Services tests of biologics 1978-1979.
    Price RJ
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):63-5. PubMed ID: 298938
    [No Abstract]   [Full Text] [Related]  

  • 34. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
    Asher DM
    Dev Biol Stand; 1999; 100():103-18. PubMed ID: 10616181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Issues confronting professional compounding in the 21st century: a student's perspective.
    Levy J
    J Am Vet Med Assoc; 1994 Jul; 205(2):297-8. PubMed ID: 7928607
    [No Abstract]   [Full Text] [Related]  

  • 36. The procedure for marketing authorization for veterinary medicinal products derived from biotechnology in the European community.
    Brunko P
    Dev Biol Stand; 1992; 79():11-5. PubMed ID: 1286745
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ideas on the organization of a national laboratory for the control of biologics].
    Nájera R; Mateos JB
    Rev Sanid Hig Publica (Madr); 1983; 57(3-4):355-7. PubMed ID: 6669911
    [No Abstract]   [Full Text] [Related]  

  • 38. Health Canada releases guidance documents for subsequent entry biologics.
    Robertson S
    Health Law Can; 2009 May; 29(3):51-2. PubMed ID: 19702237
    [No Abstract]   [Full Text] [Related]  

  • 39. Responsible drug compounding in small animal practice.
    Reid JS
    J Am Vet Med Assoc; 1994 Jul; 205(2):204-6. PubMed ID: 7928576
    [No Abstract]   [Full Text] [Related]  

  • 40. Quality assurance through residue screening.
    Engel RE
    J Am Vet Med Assoc; 1988 Jan; 192(2):268-70. PubMed ID: 3350758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.